Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
An. bras. dermatol ; 92(5,supl.1): 27-29, 2017. graf
Article in English | LILACS | ID: biblio-887056

ABSTRACT

Abstract: Clear cell acanthoma is a rare, epidermal tumor not common in the area of the nipples; indeed, the literature describes only 8 cases, all showing unilateral presentation. We here report the first case of bilateral clear cell acanthoma with good response to topical corticosteroids. Case report: A sixteen-year old girl presented with 2 excrescent, fleshy, and exudative tumor masses in both nipples and areola mammae. A biopsy was conducted and confirmed clear cell acanthoma histopathologically. Treatment with strong corticosteroids resulted in rapid improvement and resolution. After one year of follow-up, the patient developed atopic dermatitis. Discussion: We describe the first case of bilateral clear cell acanthoma localized in the nipple/areola that resolved with powerful corticosteroids, suggesting a reactive etiology of the lesion.


Subject(s)
Humans , Female , Adolescent , Skin Neoplasms/pathology , Skin Neoplasms/drug therapy , Clobetasol/administration & dosage , Acanthoma/pathology , Acanthoma/drug therapy , Glucocorticoids/administration & dosage , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/drug therapy , Nipples/pathology , Biopsy , Administration, Topical , Treatment Outcome
2.
An. bras. dermatol ; 89(5): 803-805, Sep-Oct/2014. graf
Article in English | LILACS | ID: lil-720802

ABSTRACT

Although uncommonly diagnosed, clear cell acanthoma represents an original source of speculative interest for dermatologists. Due to its clinical variability, it is often only recognized accidentally after histology. Dermoscopy has improved the reliability of clinical diagnosis of typical clear cell acanthoma thanks to the vascular pinpoint pattern and desquamative, peripheral collarette. Generally, therapy of clear cell acanthoma is oriented towards ablative solutions, such as surgery or cryotherapy. We propose a conservative therapy, based on the application of topical calcipotriol, which has produced complete regression after 2 months and no relapse one year after the end of treatment. A dermatoscope monitored all changes of clear cell acanthoma, showing its utility not only in diagnosis but also in therapeutic follow-up. This new therapeutic approach should support an inflammatory etiology of clear cell acanthoma, although further observations are needed to confirm this.


Subject(s)
Aged , Humans , Male , Acanthoma/drug therapy , Calcitriol/analogs & derivatives , Dermatologic Agents/therapeutic use , Skin Neoplasms/drug therapy , Administration, Cutaneous , Antineoplastic Agents/therapeutic use , Calcitriol/therapeutic use , Dermoscopy , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL